BRIX1 and urinary bladder neoplasm: Immunohistochemistry in surgical specimens further showed decreased expression of BXDC2 in bladder tumors, compared with non-neoplastic urothelial tissues, especially in high-grade, muscle-invasive, and/or lymph node-positive cases.